[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Poster Presentations - THU0700 Immunogenicity in patients switching from stable originator infliximab treatment to CT-P13: analyses across six diseases from the 52-week randomized nor-switch study
Goll, GL, Olsen, IC, Lundin, KEA, Jørgensen, KK, Lorentzen, M, Klaasen, RA, Warren, DJ, Mørk, C, Jahnsen, J, Haavardsholm, EA, Kvien, TK, Bolstad, NLanguage:
english
DOI:
10.1136/annrheumdis-2017-eular.4112
File:
PDF, 158 KB
english